1

Exhibit 99.2

Copyright ©

2008 AllscriptsMisys Healthcare Solutions, Inc.

The Right Place at the Right Time

Allscripts Investor Presentation

3

Forward Looking Statements

This

communication

contains

forward-looking

statements

within

the

meaning

of

the

federal

securities

laws.

Statements

regarding

future

events,

developments,

the

Company’s

future

performance,

as

well

as

management’s

expectations,

beliefs,

intentions,

plans,

estimates

or

projections

relating

to

the

future

are

forward-

looking

statements

within

the

meaning

of

these

laws.

These

forward-looking

statements

are

subject

to

a

number

of

risks

and

uncertainties,

some

of

which

are

outlined

below.

As

a

result,

actual

results

may

vary

materially

from

those

anticipated

by

the

forward-looking

statements.

Among

the

important

factors

that

could

cause

actual

results

to

differ

materially

from

those

indicated

by

such

forward-looking

statements

are:

the

volume

and

timing

of

systems

sales

and

installations;

length

of

sales

cycles

and

the

installation

process;

the

possibility

that

products

will

not

achieve

or

sustain

market

acceptance;

the

timing,

cost

and

success

or

failure

of

new

product

and

service

introductions,

development

and

product

upgrade

releases;

competitive

pressures

including

product

offerings,

pricing

and

promotional

activities;

our

ability

to

establish

and

maintain

strategic

relationships;

undetected

errors

or

similar

problems

in

our

software

products;

compliance

with

existing

laws,

regulations

and

industry

initiatives

and

future

changes

in

laws

or

regulations

in

the

healthcare

industry;

possible

regulation

of

the

Company’s

software

by

the

U.S.

Food

and

Drug

Administration;

the

possibility

of

product-related

liabilities;

our

ability

to

attract

and

retain

qualified

personnel;

our

ability

to

identify

and

complete

acquisitions,

manage

our

growth

and

integrate

acquisitions;

the

ability

to

recognize

the

benefits

of

the

merger

with

Misys

Healthcare

Systems,

LLC

(“MHS”);

the

integration

of

MHS

with

the

Company

and

the

possible

disruption

of

current

plans

and

operations

as

a

result

thereof;

maintaining

our

intellectual

property

rights

and

litigation

involving

intellectual

property

rights;

risks

related

to

third-party

suppliers;

our

ability

to

obtain,

use

or

successfully

integrate

third-party

licensed

technology;

breach

of

our

security

by

third

parties;

and

the

risk

factors

detailed

from

time

to

time

in

our

reports

filed

with

the

Securities

and

Exchange

Commission,

including

our

2007

Annual

Report

on

Form

10-K

available

through

the

Web

site

maintained

by

the

Securities

and

Exchange

Commission

at

www.sec.gov.

The

Company

undertakes

no

obligation

to

update

publicly

any

forward-looking

statement,

whether

as

a

result

of

new

information,

future

events

or

otherwise.

4

Large & Troubled . . .

Our U.S. Healthcare Scorecard

$2.2 Trillion

Spent in Healthcare

$700 Billion

in Waste

98,000 Deaths

from Medical Errors

1.5 Million

Injuries 

7,000 Deaths

from Medication Errors

5

Key Trends Driving Change

›

Rising Cost and the Parties Responsible for Payment

›

New Competitors for Physician Groups

›

Patients Are Not Patient Anymore

›

New Payment Structures and Metrics

6

The Role of Technology

›

Increase the Quality of Care

›

Take Costs Out

›

Improve Patient Safety

›

Increase Patient Satisfaction

Technology is the Enabler

The End Game is Information

7

The Healthcare Market Is Ripe for Change

›

Less Than 20% Physician Penetration

›

Less Than 10% in Smaller Groups

›

Lower IT Investment than Any Other Sector

<20

%

<10

%

8

The Opportunity for AllscriptsMisys

›

Two market leaders come together

›

Perfectly positioned to win in a vibrant, growing market

-

Electronic Health Record

-

Revenue Cycle Management

›

$1B cross-sell opportunity within our base

›

Stability from $400M+ in recurring revenue

9

Our DNA –

Blending Two Into One

Clear Goal:

Ready to Deliver on Day 1

Sales Force Integration

Product Strategy

Leadership Team

Brand

Integration Organized Around 13 Workstreams

10

In the Last Three Weeks…

11

›

Clear Mission

-

To be the clear leader in providing innovative software, connectivity and

information solutions that empower physicians and other healthcare

providers

to

improve

the

health

of

both

their

patients

and

their

bottom

line

›

Financially Strong

-

Revenue of ~ $700mm (Recurring Revenue ~ $400mm)

-

Publicly-Traded (Nasdaq: MDRX)

›

Experienced Team

-

2,500+ Employees

About the new

Allscripts

12

12

Waves of Healthcare IT Adoption

Practice

Management

Market

Enhance the

effectiveness of the

practice

Misys Leadership in Building

Practice Management / Claims

Management Client Base

Wave

1

Electronic          

Health Record

Market

Enhance the efficiency and

quality of the visit

Allscripts Leadership in EHR

Product and Blue Chip

Client Base

Wave

2

AllscriptsMisys Leadership in

New Solutions and Services

Connectivity

and

Information

Market

Enhance the health of the

patient and the practices

bottom line

Wave

3

13

It’s Time to Connect to Health™

NOTE:

INSERT CONNECT TO HEALTH VIDEO

14

Why We Win

›

Significant Footprint:

150,000 MDs, 700 Hospitals,

6,000 Post Acute Facilities, 600 Homecare Agencies

›

All Sizes and Settings:

Ambulatory and Acute,

Primary Care and Specialty, Small to Large

›

Diversified Portfolio:

Clinical and Business Solutions,

Acute and Ambulatory

›

All World-Class:

Top Rated Consistently

›

Significant Breakthroughs:

Innovation Comes Standard

›

Real Utilization:

Not Just Implementation

›

Strong ROI:

The Solution That Pays You Back

›

Delivering the Next Step:

Connect to Health™

15

Connect Solutions

•

Connect Portal

•

Connect Messaging Services

Community Care

……

……

Clinical Solutions

•

Professional EHR

•

Enterprise EHR

•

MyWay

•

ePrescribe

•

Document Management

•

Medication Services

•

Clinical Trials

•

Patient Access Solutions

Business Solutions

•

PM/ Revenue Cycle Services

•

Payerpath / EDI

Ambulatory

Practices

Emergency Department

Care Management

•

Utilization Management

•

Discharge Planning

•

Documentation Integrity

•

Quality Management

Stark Offerings

•

EHR Solutions

•

ePrescribe

Acute

Care

Homecare

•

Home Health & Private Duty

•

Hospice

Referral Management

•

Referral Management Plus

•

Mobile

•

Core System Integration

Post-Acute

Care

Our Portfolio –

We Will Connect the Market

16

Bloomberg of Healthcare

17

Our Client Base

150,000 MDs and 700+ Hospitals Across the U.S.

18

18

Professional EHR + PM

EDI

~40% penetration

1.3k practices

65k physicians

Enterprise EHR + PM

EDI

~10% penetration

170k practices

241k physicians

Professional EHR + PM

ASP-Based EHR

EDI

Segment

Allscripts Offering

Penetration/Size

~20% penetration

33k practices

227k physicians

Independent

Practices

1-3 physicians

Leadership Across the Ambulatory Market

Small to Mid-Sized

Physician Practices

4-25 Physicians

Large Physician

Practices

26-200+ Physicians

19

Market Opportunity

~ 500,000 U.S. Practicing Physicians

x          80% EHR Market Opportunity

x  ~$12,000 Initial Investment/Physician

= ~$5 Billion Opportunity

Electronic Health Record (EHR) Market = ~ $5 Billion

Practice Management (PM) Market = ~ $1 Billion/Yr.

~10% to 20% of PM Systems Replaced/Yr.

Software Maintenance Agreement (SMA) = ~ $1 Billion/Yr.

Clinical and EDI Transaction Fees = ~ $1 to 3 Billion/Yr.

American Presidential candidates see technology as the answer to

a

better healthcare delivery system

20

Summary

a complete portfolio

of solutions…

for practices in all sizes/areas…

a footprint of 1 of 3 MDs

in the U.S.

Products

Target

Client Base

21

Financial Overview

*

*

*

*

*

22

Q3 2008 Preliminary Overview

›

Q3 Results will be finalized and filed with the SEC on 11/10/2008

›

Updated Estimates for Q3

-

Bookings

-

$44.6m for the quarter and $152.5m YTD

-

$41.8m clinical bookings for the quarter and $143.1m YTD

-

Revenue

-

$85.7m for the quarter and $239.3m YTD

-

$71.8m

software

and

related

services

for

the

quarter

and

$198.6m

YTD

-

Gross Margins

-

48.8% for the quarter and 49.7% YTD

-

Adjusted Earnings

-

$8.4m

or

$0.15

per

share

for

the

quarter

and

$20.7m

or

$0.36

per

share

YTD

-

Net Income

-

$4.0m or $0.07 per share for the quarter and $6.5m or $0.11 per share YTD

-

$5.3m

or

$0.09

per

share

for

the

quarter

and

$11.2m

or

$0.19

per

share

YTD; excluding transaction cost and Physicians Interactive gain

Note: Adjusted earnings is a non-GAAP financial measure. See

reconciliation to comparable GAAP measure in Appendix A.

23

2009 Outlook

($ in millions - unaudited pro forma)

Previous

Guidance

Fiscal

Fiscal

Calendar

Guidance

2008

2008

2009

Bookings

$317.7

N/A

N/A

Revenue

$684.2

$700.0

$700.0 to $715.0

Less: PI

(15.0)

(15.0)

0.0

Adjusted Revenue

$669.2

$685.0

$700.0 to $715.0

Adjusted Earnings

$62.6

$85.0 to $90.0

$76.0 to $82.0

Less: Physicians Interactive

(1.1)

(1.0)

0.0

Less: Synergies Timing

0.0

(5.0)

0.0

Less: Amortization Timing

0.0

(4.0)

0.0

Revised Adjusted Earnings

$61.5

$75.0 to $80.0

$76.0 to $82.0

Adjusted Earnings Per Share

$0.43

$0.48 to $0.52

$0.49 to $0.53

Pro Forma Share Count

148.0

155.0

155.0

Note: Fiscal 2008 reflects actual results for Misys Healthcare (under U.S GAAP) for the year ended May 31, 2008

    and the trailing 12-months for Allscripts for the period ended June 30, 2008.

Note 2: Adjusted earnings is a non-GAAP financial measure. See reconciliation to

comparable GAAP measure on page 24.

24

Adjusted Earnings Potential

($ in millions -

unaudited pro forma)

Fiscal

Fiscal

2008

2009

Earnings Before Taxes, as reported

$57.5

$83.5 to $93.0

Taxes (Assumed @ 39%)

(22.4)

$32.5 to $36.0

Net Income

$35.1

$51.0 to $57.0

Adjustments:(tax adjusted @ 39%)

Stock-Based Compensation

$5.4

$7.0

Deal-Related Amortization

14.0

18.0

One-Time Costs / Transaction Related Expenses

8.1

-

Physicians Interactive

(1.1)

-

Total Adjustments

$26.4

$25.0

Adjusted Earnings

$61.5

$76.0 to $82.0

Adjusted Earnings Growth

42%

24% to 33%

25

Significant and Realizable Synergy Opportunity

›

Cost synergies of $20m+, pre-tax,

expected in first year following

transaction close

-

Up to $25m to $30m, pre-tax, in annual

cost savings within the next few years

-

Main drivers of cost synergies include:

R&D, Marketing, Sales, Administrative

Functions

›

Revenue synergies from cross-selling

into respective client bases is expected

to be ~$7m+ in FY 2009

›

Increased operating leverage expected

to result in mid teens EPS growth

Projected Cost Synergies

$20m+

$25 -

$30m

First Year

Run Rate

26

Illustrative Revenue Sensitivity Analysis

Four Year Cumulative Penetration Rates

110,000

MDs

20%

Assumed EHR Penetration

88,000

Addressable EHR Market

20%

30%

40%

50%

60%

License/Service Fees

$165m

$248m

$330m

$410m

$495m

Annual Maintenance

$20m

$30m

$40m

$50m

$60m

27

We Are Prepared to Execute

Vern Davenport, President

Professional Solutions

Clients:

21,000+ clients

Small to mid-sized practices

Employees:

~1,700 employees

160 sales reps (30 inside)

Laurie McGraw, President

Enterprise Solutions

Clients:

5,000 clients

Large Physicians Practices,

IDNs, and Hospitals

Employees:

~350 employees

35 sales reps (9 inside)

Jeff Surges, President

Health Systems Group

Clients:

700 hospitals

6,000 post-acute providers

600+ homecare and hospice

agencies

Employees:

~300 employees

35 sales reps (5 inside)

28

Fiscal Year 2009 Liquidity

($ in millions - unaudited pro forma)

Estimated Cash & Marketable Securities Net of

Transaction Expenses

$45.0

to

$50.0

Summary of Debt:

Drawn Portion of Revolving Credit Facility

$50.0

Convertible Notes Outstanding

27.9

Mortgage (will be paid off with proceeds from sale)

3.5

Capital Leases

1.6

Total Debt

$83.0

Net Debt

($33.0)

to

($38.0)

Undrawn Revolver Availability

$25.0

Proforma Cash Flow:

FY 2009 Adjusted Earnings

$76.0

to

$82.0

Less: Incremental Capitalized Software

(13.5)

         Incremental Capital Expenditures

(3.0)

         Change in Working Capital

(4.5)

         One-time Costs, Net of Sale of Facility Proceeds

(3.0)

(24.0)

Estimated Cash Flow

$52.0

to

$58.0

Note:  Assumes taxes are paid in cash.

29

Capital Structure

(shares in millions)

Ownership %

Allscripts Outstanding Shares

63.0

41.4%

Allscripts Shares Issued to Misys plc

82.9

54.5%

Shares Underlying Remaining Debentures

3.5

2.3%

"In the Money" Options

2.4

1.5%

Unvested Restricted Stock Units

0.4

0.2%

Outstanding Equity as of Closing

152.1

100.0%

Estimated Number of RSU Grants in FY 2009

4.0 to 4.5

Note: Debenture holders will have an opportunity to put their debentures to the company for

principal plus accrued but unpaid interest through date of 'put'.

30

Reporting Considerations

›

U.S. GAAP vs. IFRS

›

Allscripts accounting acquiree -

valuation in process

›

Deferred revenue adjustment (non-cash)

›

Effective tax rate

›

Convertible debt potential ‘put’

›

Change in auditors

›

Booking (aka Order Intake) Definition

31

The new

Allscripts Is Positioned for Profitable Growth

›

Two market leaders come together

›

Perfectly positioned to win in a vibrant, growing market

-

Electronic Health Record

-

Revenue Cycle Management

›

$10B market opportunity and $1B cross-sell opportunity

within our base

›

Stability via $400M+ in recurring revenue

33

Appendix A –

GAAP Reconciliation

Three Months Ended

Nine Months Ended

2008

2007

2008

2007

Net Income

$4.0

$4.1

$6.5

$14.6

Stock-based compensation expense (tax effected at 39% for

2008 and 40% for 2007)

1.0

0.9

3.2

1.7

Acquisition-related amortization (tax effected at 39% for

2008 and 40% for 2007)

2.1

1.7

6.3

4.7

Transaction-related expenses (tax effected at 39% for 2008)

3.3

-

6.8

-

Gain on sale of Physicians Interactive business (tax effected

at 39% for 2008)

(2.0)

-

(2.0)

-

Non-GAAP Adjusted Earnings

$8.4

$6.7

$20.7

$21.0

Weighted average shares of common stock outstanding

used in computing diluted non-GAAP adjusted earnings per

share

58.2

65.2

57.8

64.5

Non-GAAP Adjusted Earnings Per Share -

diluted

$0.15

$0.11

$0.36

$0.35

Allscripts

Healthcare

Solutions,

Inc.

September 30,

September 30,

Reconciliation of Non-GAAP Adjusted Earnings and Non-GAAP Adjusted Earnings Per Share

(amounts in millions, except per-share amounts)

(Unaudited)